Dear Editor, Recent studies show that induced pluripotent stem cells (iPSCs) generated through ectopic expression of transcription factors retain an epigenetic memory of their original somatic cells (Kim et al., 2010; Polo et al., 2010) or aberrant silencing of a single imprinted gene cluster Stadtfeld et al., 2010) , which affects their developmental and differentiation potentials. In contrast, nuclear transfer can more faithfully reprogramme somatic cells into embryonic stem (ES) cells (nuclear transfer ES cells, ntESCs) (Brambrink et al., 2006; Wakayama et al., 2006) . However, it is still controversial whether reprogramming method per se determines the pluripotency of resulting cells. Here, using genetically identical donor cells, we generated three kinds of mouse reprogrammed cells: iPSCs, ntESCs, and iPSC-nt-ESCs, after successively reprogramming of iPSCs by nuclear transfer. We found that ntESCs had better developmental potential compared with iPSCs, and following nuclear transfer can not rescue, but deteriorate the developmental deficiency of iPSCs, resulting in the worst developmental ability in iPSC-nt-ESCs.
In order to minimize genetic variations among different reprogrammed cells, we established a genetically homogenous secondary reprogramming system, in which mouse embryonic fibroblasts (MEFs) carrying doxycycline (Dox)-inducible lentiviruses expressing Oct4, Sox2, Klf4, and c-Myc (OSKM-MEFs) were isolated (Huang et al., 2009 ) and used as donors for different reprogramming experiments. To generate secondary iPS cells, OSKM-MEFs were cultured in mouse embryonic stem cell medium supplemented with Dox, which induced the expression of transgenes and initiated the reprogramming process. After exposing OSKM-MEFs to Dox for 18 days, iPS cell colonies were expanded in the absence of Dox and four iPS cell lines were established from MEF-1 and MEF-2 (iPSC-1 and iPSC-2 generated from MEF-1; iPSC-3 and iPSC-4 from MEF-2; Figure 1A ; Supplementary Figure S1A ). All iPS cell lines showed an ES-like morphology, exhibited alkaline phosphatase (AP) activity and expressed the pluripotent markers Oct4, Sox2, and SSEA-1 (see Supplementary Figure S1B ). Bisulphite sequencing analysis of endogenous Oct4 promoter of iPS cell nuclei revealed that epigenetic state of the somatic cells had been reprogrammed (Supplementary Figure S1C) . These results indicated that all iPSCs had activated their endogenous pluripotency core transcriptional network.
To generate genetic identical ntESCs, we performed nuclear transfer using the same MEFs as nucleus donors ( Figure 1A) . From 526 oocytes successfully reconstructed with the nuclei of MEF-1 and MEF-2, we cloned blastocysts and established a set of 12 ntES cell lines (Supplementary Table S1 ). Next, to test whether successively reprogramming by nuclear transfer could result in reprogrammed cells with better developmental potential ( Figure 1A) , we transferred the nucleus of iPSCs into enucleated oocyte. From 324 successfully reconstructed oocytes with nucleus from four iPS cell lines, we established a second set of 24 ntES cell lines (Supplementary Table S1 ), which were referred to as iPSC-nt-ES cell lines to reflect the combination of nuclear transfer and iPS technologies. We confirmed that iPSCs, ntESCs, and iPSC-nt-ESCs were exactly derived from the MEF-1 or MEF-2 by PCR for strainspecific length polymorphism (SSLP) ( Figure 1B) . Together, we generated genetically matched mouse pluripotent stem cells, providing a comparable system to study the discrepancies among the reprogrammed cells derived by different strategies.
iPSCs, ntESCs, and iPSC-nt-ESCs were expanded in standard mouse ES culture medium and their pluripotent potentials were analysed parallel. All of them showed morphology similar to mouse ESCs from the well-characterized E14 cell line and were positive for AP activity ( Figure 1C ). Karyotype analysis demonstrated these cell lines predominantly have 40 chromosomes (data not shown). Real-time quantitative PCR indicated that all of them expressed similar level of endogenous Oct4 and Nanog ( Figure 1D ). To test the differentiation potency of these pluripotent stem cells in vitro, we used a standard embryoid body (EB)-based ES differentiation protocol for cardiac differentiation. We observed that plated ntESC-derived EBs had spontaneously contracting areas on day 12 of differentiation, while iPSC and iPSC-nt-ESC-derived EBs started beating on day 15 of differentiation. The percentage of contracting areas continued to increase in EBs from three kinds of reprogrammed cells ( Figure 1E) ; however, iPSC-derived beating clusters were usually the smallest and those in ntESC-EBs were the largest. These results showed that iPSCs and iPSC-nt-ESCs had delayed and less efficient cardiac differentiation compared with ntESCs, which is consistent with Mauritz et al. (2008) on the different cardiac differentiation potential between iPSCs and ESCs.
Next, we test the developmental abilities of iPSCs, ntESCs, and iPSC-nt-ESCs in vivo by injecting them into tetraploid and diploid blastocysts, respectively (Supplementary Table S2 ). ntESCs (ntESC-1 derived from MEF-1 and ntESC-2 from MEF-2) could give rise to viable mice after complemented with tetraploid blastocysts ( Figure 1F , left) at efficiency similar to Li and Mombaerts (2008) . In contrast, all iPSCs and corresponding iPSC-nt-ESCs failed to generate entirely stem cellderived mice (Supplementary Table S2 ), reflecting that ground state of pluripotency was not acquired during iPSCs and iPSC-nt-ESCs formation. We then injected iPSCs and iPSC-nt-ESCs into diploid blastocysts of ICR origin. Chimeric mice were generated from all of them ( Figure 1F , middle and right; Supplementary Tables S2 and  S3 ) and the extent of chimaerism was evaluated based on black coat colour of injected cells. Interestingly, the rate of coat colour chimaerism in mice generated from iPSC-nt-ESCs was significantly lower than that of iPSCs (22.3 + 20.4 vs. 39.3 + 24.9; P ¼ 0.025; Figure 1G ; Supplementary Table S3) , although iPSC-1 showed less efficient cardiac differentiation compared with the corresponding iPSC-nt-ESC-1. Similar differences in differentiation and developmental potential are observed among individual ES cell lines, and the observed in vitro differentiation and in vivo developmental discrepancies between iPSC-1 and iPSC-nt-ESC-1 may reflect similar clonal differences. These results indicate that different developmental potentials present in pluripotent stem cells derived from different reprogramming methods and nuclear transfer did not rescue, but deteriorated the developmental properties of iPSCs.
Finally, we compared the gene expression profile of all reprogrammed cell lines with the normal ES cell line, E14. Unsupervised hierarchical clustering of these cell lines based on microarray expression data clearly placed ntESCs, iPSCs, and iPSC-nt-ESCs into different groups according to reprogramming methods ( Figure 1H) . Moreover, ntESCs clustered more closely with normal mouse ESCs than the iPSCs and iPSC-nt-ESCs. These results suggested that nuclear transfer ensures faithfully reprogramming of somatic cells to a 'ground state' of pluripotency similar to that of fertilization-derived ESCs. Interestingly, iPSCs from the same MEFs clustered together, indicating that the same cell type from different foetuses may influence the gene expression profiling of resulting iPSCs, probably due to the existence of epigenetic memory of donors in iPSCs (Kim et al., 2010; Polo et al., 2010) .
Recent reports indicate that nuclear transfer can generate ESC-equivalent pluripotent stem cells more effectively than factor-based reprogramming (Kim et al., 2010; Polo et al., 2010) . However, ntESCs and iPSCs compared in these studies were not derived from genetically identical donor cells, which could not exclude the possibility that different genetic background or transgene integration determines the gene expression patterns and differentiation capacities of reprogrammed cells. To circumvent this potential limitation, we used the same donor cells for different reprogramming strategies and generated three kinds of genetically matched reprogrammed cells. We found that nuclear transfer can result in reprogrammed cells with the better developmental capacity when compared with iPSCs generated by transcription-factorbased reprogramming. Our comparative study suggests that the failure of generation of iPSC mice through tetraploid embryo complementation is due to not the viral transgene insertions, but the reprogramming process driven by ectopic expression of transcription factors. To our knowledge, this is the first demonstration of reprogramming methods per se determining the distinguishable developmental capacities of ntESCs and iPSCs. Furthermore, to rescue the developmental deficiency of iPSCs, we performed nuclear transfer using iPSCs as donors. Unexpectedly, resultant iPSC-nt-ESCs showed even worse developmental potentials compared with their originated iPSCs, indicating that aberrant gene expression pattern established during iPSC derivation cannot be reset by nuclear transfer, probably due to the genetic aberrations acquired during iPSC formation (Pera, 2011) . This result confirms that faulty gene expression existed in iPSCs (Stadtfeld et al., 2010) or ESCs (Humpherys et al., 2001) can not be reset in products generated by nuclear transfer. Together, our findings demonstrate that nuclear transfer can reprogramme somatic cells to a 'ground state' of pluripotency more frequently than factormediated reprogramming, but cannot reverse the developmental deficiency of iPSCs. Therefore, it is intriguing to identify reprogramme factors in oocyte cytoplasm and utilize them in 'Yamanaka method' to enhance the efficiency and quality of reprogrammed cells. 
